LONA
HEALTHCAREAthira Pharma Inc
$9.42-0.21 (-2.18%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving LONA Today?
No stock-specific AI insight has been generated for LONA yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$2.49$14.21
$9.42
Fundamentals
Market Cap$88M
P/E Ratio—
EPS$-24.70
Dividend Yield—
Dividend / Share—
ROE-2.9%
Profit Margin—
Debt / Equity—
Trading
Volume20K
Avg Volume (10D)—
Shares Outstanding9.4M
LONA News
6 articles- LeonaBio Reports First Quarter 2026 Financial Results and Provides Business UpdateYahoo Finance·May 7, 2026
- LeonaBio Enhances Board of Directors with Appointments of Fred Callori, J.D., Natalie Holles and Peter B. Silverman, J.D.Yahoo Finance·May 7, 2026
- LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast CancerYahoo Finance·Apr 23, 2026
- Independent Nonclinical Research on Lasofoxifene Presented at American Association for Cancer Research Annual Meeting 2026 Consistent with LeonaBio’s DataYahoo Finance·Apr 21, 2026
- LeonaBio Reports Full Year 2025 Financial Results and Provides Business UpdateYahoo Finance·Mar 26, 2026
- LeonaBio Appoints Industry Veteran Mark F. Kubik as Chief Business OfficerYahoo Finance·Feb 3, 2026
All 6 articles loaded
Price Data
Open$9.62
Previous Close$9.63
Day High$9.85
Day Low$9.32
52 Week High$14.21
52 Week Low$2.49
52-Week Range
$2.49$14.21
$9.42
Fundamentals
Market Cap$88M
P/E Ratio—
EPS$-24.70
Dividend Yield—
Dividend / Share—
ROE-2.9%
Profit Margin—
Debt / Equity—
Trading
Volume20K
Avg Volume (10D)—
Shares Outstanding9.4M
About Athira Pharma Inc
LeonaBio, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company is headquartered in Bothell, Washington.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—